Search results
Zydus barred from selling cancer biosimilar, for now
The Economic Times· 6 days agoThe Delhi High Court has issued an interim injunction, restraining Zydus Lifesciences from selling its breast cancer drug Sigrima - a biosimilar version of Roche's Perjeta ...
Man Wah issues a shipping surcharge, falling occupancy poses a $30 million threat to the D&D...
BUSINESS OF HOME· 7 days agoThis week in design, a new collectible art and design fair in Shanghai, West Elm tapped chef and...
Mint Primer | Trump’s murder attempt: What it means for us
Livemint· 1 day agoWhat do we know so far about the assassination attempt? The shooter, 20-year-old Thomas Mathew...
Our Best Stuff From Another Rollercoaster Ride of a Week
The Dispatch· 3 days agoAnd here’s the best of the rest. When a Russian missile struck a children’s hospital in Kyiv, Joseph...
‘Why Do They Attack Children?’
The Dispatch· 5 days agoWe went inside the hospital and started helping the injured. I then saw a drone flying and exploding in a building a bit further away.” Nikita, one of...
iOnctura expands PI3K inhibitor programme to NSCLC
Pharmaceutical Technology· 7 days agoThe decision was based on high levels of fatal adverse events (AEs) and toxicity observed in patients taking the drug class. Roche made a recent...
Illumina buys Fluent Biosciences, adding single-cell analysis tech
MedTech Dive· 6 days agoFluent is one of the startups. The company’s kits segregate cell mixtures into partitions with...
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive· 4 days agoSales data suggest forecasts for the Alzheimer’s drug may be in reach. Elsewhere, a well-funded DNA...
Daily Morning Newsletter
The Economic Times· 6 days agoFind the latest information & technology news, views and updates from all top sources for the Indian IT industry.
“We Have to Earn it” – Arsenal Star Issues Rally Cry Ahead of the New Premier League Season
EPL Index· 7 days agoMartin Odegaard: Mastering Arsenal’s Premier League QuestArsenal’s Tactical Preparation Under...
